Publicacións nas que colabora con Susana Mirás Carballal (7)

2024

  1. Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  2. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study

    The Lancet Infectious Diseases

  3. Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study

    Pediatric Allergy and Immunology, Vol. 35, Núm. 5

2023

  1. COVID-19 vaccine effectiveness in children by age groups. A population-based study in Galicia, Spain

    Pediatric Allergy and Immunology, Vol. 34, Núm. 10

  2. Early lessons from the implementation of universal respiratory syncytial virus prophylaxis in infants with long-acting monoclonal antibodies, Galicia, Spain, September and October 2023

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 49

  3. Improving Influenza Vaccine Acceptance in Children Leveraging on COVID-19 Vaccination Lessons

    Archivos de Bronconeumologia, Vol. 59, Núm. 8, pp. 531-533

2022

  1. Effectiveness of COVID-19 vaccine booster in the general population and in subjects with comorbidities. A population-based study in Spain

    Environmental Research, Vol. 215